Angiocrine Bioscience
0 followers
‌
Angiocrine Bioscience is a private, clinical-stage cell and gene therapy company harnessing the power of genetically modified human endothelial cells to regenerate tissues, restore function and rejuvenate patients with serious medical conditions.
Industries
Headquarters
Employees
Links
Org chart
Paul Finnegan
Collapse
John Lomoro
CFO
John K. Fraser
Chief Scientific Officer
Lee Landeen
Executive Director, Pre-clinical Development
Michael Ginsberg
Senior Director, Product Development
Margie Breneman
Senior Director, Project Management
Daniel J. Nolan
Director, External Research
Geoff Davis
President And CSO
Gayle Bresnahan
Director, Clinical Operations
Kathy K. Park
Associate Director Clinical Operations
